Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Revenue (2021)

Historic Revenue for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2021 value amounting to $192.2 million.

  • Atea Pharmaceuticals' Revenue changed N/A to $192.2 million in Q4 2021 from the same period last year, while for Sep 2022 it was $192.2 million, marking a year-over-year increase of 2072.59%. This contributed to the annual value of $351.4 million for FY2021, which is 62248.68% up from last year.
  • As of Q4 2021, Atea Pharmaceuticals' Revenue stood at $192.2 million.
  • Atea Pharmaceuticals' 5-year Revenue high stood at $192.2 million for Q4 2021, and its period low was $32.8 million during Q3 2021.